1.Rasouli MR, Tripathi MS, Kenyon R, Wetters N, Della Valle CJ, Parvizi J: Low rate of infection control in enterococcal periprosthetic joint infections. Clinical orthopaedics and related research 2012, 470(10):2708–2716.
2.Fernandes A, Dias M: The Microbiological Profiles of Infected Prosthetic Implants with an Emphasis on the Organisms which Form Biofilms. J Clin Diagn Res 2013, 7(2):219–223.
3.Peel TN, Buising KL, Dowsey MM, Aboltins CA, Daffy JR, Stanley PA, Choong PF: Outcome of debridement and retention in prosthetic joint infections by methicillin-resistant staphylococci, with special reference to rifampin and fusidic acid combination therapy. Antimicrobial agents and chemotherapy 2013, 57(1):350–355.
4.Cobo J, Miguel LG, Euba G, Rodriguez D, Garcia-Lechuz JM, Riera M, Falgueras L, Palomino J, Benito N, del Toro MD et al: Early prosthetic joint infection: outcomes with debridement and implant retention followed by antibiotic therapy. Clin Microbiol Infect 2011, 17(11):1632–1637.
5.Murray BE: The life and times of the Enterococcus. Clin Microbiol Rev 1990, 3(1):46–65.
6.Zimmerli W, Trampuz A, Ochsner PE: Prosthetic-joint infections. N Engl J Med 2004, 351(16):1645–1654.
7.Soriano A, Garcia S, Bori G, Almela M, Gallart X, Macule F, Sierra J, Martinez JA, Suso S, Mensa J: Treatment of acute post-surgical infection of joint arthroplasty. Clin Microbiol Infect 2006, 12(9):930–933.
8.Lora-Tamayo J, Euba G, Ribera A, Murillo O, Pedrero S, García-Somoza D, Pujol M, Cabo X, Ariza J: Infected hip hemiarthroplasties and total hip arthroplasties: Differential findings and prognosis. Journal of Infection, 67(6):536–544.
9.Kheir MM, Tan TL, Higuera C, George J, Della Valle CJ, Shen M, Parvizi J: Periprosthetic Joint Infections Caused by Enterococci Have Poor Outcomes. The Journal of arthroplasty 2017, 32(3):933–947.
10.Tornero E, Senneville E, Euba G, Petersdorf S, Rodriguez-Pardo D, Lakatos B, Ferrari MC, Pilares M, Bahamonde A, Trebse R et al: Characteristics of prosthetic joint infections due to Enterococcus sp. and predictors of failure: a multi-national study. Clin Microbiol Infect 2014, 20(11):1219–1224.
11.Duijf SV, Vos FJ, Meis JF, Goosen JH: Debridement, antibiotics and implant retention in early postoperative infection with Enterococcus sp. Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2015, 21(5):e41–42.
12.El Helou OC, Berbari EF, Marculescu CE, El Atrouni WI, Razonable RR, Steckelberg JM, Hanssen AD, Osmon DR: Outcome of enterococcal prosthetic joint infection: is combination systemic therapy superior to monotherapy? Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 2008, 47(7):903–909.
13.Osmon DR, Berbari EF, Berendt AR, Lew D, Zimmerli W, Steckelberg JM, Rao N, Hanssen A, Wilson WR, Infectious Diseases Society of A: Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2013, 56(1):e1-e25.
14.Tande AJ, Patel R: Prosthetic joint infection. Clin Microbiol Rev 2014, 27(2):302–345.
15.Euba G, Lora-Tamayo J, Murillo O, Pedrero S, Cabo J, Verdaguer R, Ariza J: Pilot study of ampicillin-ceftriaxone combination for treatment of orthopedic infections due to Enterococcus faecalis. Antimicrob Agents Chemother 2009, 53(10):4305–4310.
16.Holmberg A, Morgelin M, Rasmussen M: Effectiveness of ciprofloxacin or linezolid in combination with rifampicin against Enterococcus faecalis in biofilms. J Antimicrob Chemother 2012, 67(2):433–439.
17.Oliva A, Furustrand Tafin U, Maiolo EM, Jeddari S, Betrisey B, Trampuz A: Activities of fosfomycin and rifampin on planktonic and adherent Enterococcus faecalis strains in an experimental foreign-body infection model. Antimicrobial agents and chemotherapy 2014, 58(3):1284–1293.
18.Descourouez JL, Jorgenson MR, Wergin JE, Rose WE: Fosfomycin synergy in vitro with amoxicillin, daptomycin, and linezolid against vancomycin-resistant Enterococcus faecium from renal transplant patients with infected urinary stents. Antimicrob Agents Chemother 2013, 57(3):1518–1520.
19.Yuste JR, Quesada M, Diaz-Rada P, Del Pozo JL: Daptomycin in the treatment of prosthetic joint infection by Enterococcus faecalis: safety and efficacy of high-dose and prolonged therapy. Int J Infect Dis 2014, 27:65–66.
20.Renz N, Yermak K., Perka C., Trampuz A.: Alpha defensin lateral flow test for diagnosis of periprosthetic joint infection. Not a screening but a confirmatory test. . J Bone Joint Surg Am 2018(100(9)):742–750.
21.Zimmerli W: Clinical presentation and treatment of orthopaedic implant-associated infection. Journal of internal medicine 2014, 276(2):111–119.
22.Krenn V, Morawietz L, Perino G, Kienapfel H, Ascherl R, Hassenpflug GJ, Thomsen M, Thomas P, Huber M, Kendoff D et al: Revised histopathological consensus classification of joint implant related pathology. Pathol Res Pract 2014, 210(12):779–786.
23.Trampuz A, Piper KE, Jacobson MJ, Hanssen AD, Unni KK, Osmon DR, Mandrekar JN, Cockerill FR, Steckelberg JM, Greenleaf JF et al: Sonication of removed hip and knee prostheses for diagnosis of infection. N Engl J Med 2007, 357(7):654–663.
24.Tornero E, Soriano A: Prosthetic joint infection due to Enterococcus sp treated with debridement, antibiotics and retention of the implant (DAIR). Clin Microbiol Infect 2015, 21(5):e43–44.
25.The European Committee on Antimicrobial Susceptibility Testing (EUCAST) (2018) Breakpoint tables for interpretation of MICs and zone diameters. version 8.0 2018, http://www.eucast.org/clinical_breakpoints.
26.Jindai K, Strerath MS, Hess T, Safdar N: Is a single positive blood culture for Enterococcus species representative of infection or contamination? Eur J Clin Microbiol Infect Dis 2014, 33(11):1995–2003.
27.Rakow A, Perka C, Trampuz A, Renz N: Origin and characteristics of haematogenous periprosthetic joint infection. Clinical Microbiology and Infection 2018.